acquired metabolic disease

Literature (48)

Literature for DOID 0060158: acquired metabolic disease

Xenbase Articles Publications associated with this Disease Ontology entry or its descendants

:
(

Denotes literature images)

A gating mutation at the internal mouth of the Kir6.2 pore is associated with DEND syndrome., Proks P,Girard C,Haider S,Gloyn AL,Hattersley AT,Sansom MS,Ashcroft FM, EMBO Rep. May 1, 2005; 6(5):1469-3178.
A structural basis for the acute effects of HIV protease inhibitors on GLUT4 intrinsic activity., Hertel J,Struthers H,Horj CB,Hruz PW, J Biol Chem. December 31, 2004; 279(53):1083-351X.
Functional characterization of two naturally occurring mutations in the human sodium-phosphate cotransporter type IIa., Virkki LV,Forster IC,Hernando N,Biber J,Murer H, J Bone Miner Res. December 1, 2003; 18(12):0884-0431.
The cloning of extracellular Ca(2+)-sensing receptors from parathyroid and kidney: molecular mechanisms of extracellular Ca(2+)-sensing., Brown EM,Pollak M,Chou YH,Seidman CE,Seidman JG,Hebert SC, J Nutr. July 1, 1995; 125(7 Suppl):1541-6100.
Molecular cloning, functional expression, tissue distribution, and in situ hybridization of the renal sodium phosphate (Na+/P(i)) transporter in the control and hypophosphatemic mouse., Collins JF,Ghishan FK, FASEB J. August 1, 1994; 8(11):1530-6860.
Characterization of the defect in the Na(+)-phosphate transporter in vitamin D-resistant hypophosphatemic mice., Nakagawa N,Arab N,Ghishan FK, J Biol Chem. July 25, 1991; 266(21):1083-351X.
A heterozygous activating mutation in the sulphonylurea receptor SUR1 (ABCC8) causes neonatal diabetes., Proks P,Arnold AL,Bruining J,Girard C,Flanagan SE,Larkin B,Colclough K,Hattersley AT,Ashcroft FM,Ellard S, Hum Mol Genet. June 1, 2006; 15(11):1460-2083.
Transcription factor HNF1beta and novel partners affect nephrogenesis., Dudziak K,Mottalebi N,Senkel S,Edghill EL,Rosengarten S,Roose M,Bingham C,Ellard S,Ryffel GU, Kidney Int. July 1, 2008; 74(2):1523-1755.
Promoting ectopic pancreatic fates: pancreas development and future diabetes therapies., Pearl EJ,Horb ME, Clin Genet. October 1, 2008; 74(4):1399-0004.
An alpha7 nicotinic acetylcholine receptor-selective agonist reduces weight gain and metabolic changes in a mouse model of diabetes., Marrero MB,Lucas R,Salet C,Hauser TA,Mazurov A,Lippiello PM,Bencherif M, J Pharmacol Exp Ther. January 1, 2010; 332(1):1521-0103.
Human sodium phosphate transporter 4 (hNPT4/SLC17A3) as a common renal secretory pathway for drugs and urate., Jutabha P,Anzai N,Kitamura K,Taniguchi A,Kaneko S,Yan K,Yamada H,Shimada H,Kimura T,Katada T,Fukutomi T,Tomita K,Urano W,Yamanaka H,Seki G,Fujita T,Moriyama Y,Yamada A,Uchida S,Wempe MF,Endou H,Sakurai H, J Biol Chem. November 5, 2010; 285(45):1083-351X.
Tamm-Horsfall glycoprotein interacts with renal outer medullary potassium channel ROMK2 and regulates its function., Renigunta A,Renigunta V,Saritas T,Decher N,Mutig K,Waldegger S, J Biol Chem. January 21, 2011; 286(3):1083-351X.
Transient expression of Ngn3 in Xenopus endoderm promotes early and ectopic development of pancreatic beta and delta cells., Oropeza D,Horb M, Genesis. March 1, 2012; 50(3):1526-968X.
Towards a humanized PPARγ reporter system for in vivo screening of obesogens., Punzon I,Latapie V,Le Mével S,Hagneau A,Jolivet P,Palmier K,Fini JB,Demeneix BA, Mol Cell Endocrinol. July 15, 2013; 374(1-2):1872-8057.
The unusual stoichiometry of ADP activation of the KATP channel., Hosy E,Vivaudou M, Front Physiol. January 28, 2014; 5:1664-042X.
Recessive mutations in PCBD1 cause a new type of early-onset diabetes., Simaite D,Kofent J,Gong M,Rüschendorf F,Jia S,Arn P,Bentler K,Ellaway C,Kühnen P,Hoffmann GF,Blau N,Spagnoli FM,Hübner N,Raile K, Diabetes. October 1, 2014; 63(10):1939-327X.
Inhibitory effects of insulin on GABAA currents modulated by the GABAA alpha subunit., Williams DB, J Recept Signal Transduct Res. January 1, 2015; 35(6):1532-4281.
Autosomal-Recessive Mutations in SLC34A1 Encoding Sodium-Phosphate Cotransporter 2A Cause Idiopathic Infantile Hypercalcemia., Schlingmann KP,Ruminska J,Kaufmann M,Dursun I,Patti M,Kranz B,Pronicka E,Ciara E,Akcay T,Bulus D,Cornelissen EA,Gawlik A,Sikora P,Patzer L,Galiano M,Boyadzhiev V,Dumic M,Vivante A,Kleta R,Dekel B,Levtchenko E,Bindels RJ,Rust S,Forster IC,Hernando N,Jones G,Wagner CA,Konrad M, J Am Soc Nephrol. February 1, 2016; 27(2):1533-3450.
Xenopus as a Model for GI/Pancreas Disease., Salanga MC,Horb ME, Curr Pathobiol Rep. June 1, 2015; 3(2):2167-485X.
Xenopus as a model system for studying pancreatic development and diabetes., Kofent J,Spagnoli FM, Semin Cell Dev Biol. March 1, 2016; 51:1096-3634.
Using Xenopus to study genetic kidney diseases., Lienkamp SS, Semin Cell Dev Biol. March 1, 2016; 51:1096-3634.
Successful transfer to sulfonylureas in KCNJ11 neonatal diabetes is determined by the mutation and duration of diabetes., Babiker T,Vedovato N,Patel K,Thomas N,Finn R,Männikkö R,Chakera AJ,Flanagan SE,Shepherd MH,Ellard S,Ashcroft FM,Hattersley AT, Diabetologia. June 1, 2016; 59(6):1432-0428.
Using Xenopus to understand human disease and developmental disorders., Sater AK,Moody SA, Genesis. January 1, 2017; 55(1-2):1526-968X.
Micellar Nanomedicine of Novel Fatty Acid Modified Xenopus Glucagon-like Peptide-1: Improved Physicochemical Characteristics and Therapeutic Utilities for Type 2 Diabetes., Han J,Fei Y,Zhou F,Chen X,Zheng W,Fu J, Mol Pharm. November 6, 2017; 14(11):1543-8392.
A comparative genomics study of carbohydrate/glucose metabolic genes: from fish to mammals., Zhang Y,Zhang Y,Qin C,Yang L,Lu R,Zhao X,Nie G, BMC Genomics. April 11, 2018; 19(1):1471-2164.
Binding of sulphonylureas to plasma proteins - A KATP channel perspective., Proks P,Kramer H,Haythorne E,Ashcroft FM, PLoS One. May 15, 2018; 13(5):1932-6203.
Rational design of dimeric lipidated Xenopus glucagon-like peptide 1 analogues as long-acting antihyperglycaemic agents., Han J,Huang Y,Chen X,Zhou F,Fei Y,Fu J, Eur J Med Chem. September 5, 2018; 157:1768-3254.
Inactivation of KCNQ1 potassium channels reveals dynamic coupling between voltage sensing and pore opening., Hou P,Eldstrom J,Shi J,Zhong L,McFarland K,Gao Y,Fedida D,Cui J, Nat Commun. November 23, 2017; 8(1):2041-1723.
Activation of the calcium sensing receptor attenuates TRPV6-dependent intestinal calcium absorption., Lee JJ,Lee JJ,Liu X,O'Neill D,Beggs MR,Weissgerber P,Flockerzi V,Chen XZ,Dimke H,Alexander RT, JCI Insight. April 23, 2019; 5:2379-3708.
ANP-stimulated Na+ secretion in the collecting duct prevents Na+ retention in the renal adaptation to acid load., Cheval L,Bakouh N,Walter C,Tembely D,Morla L,Escher G,Vogt B,Crambert G,Planelles G,Doucet A, Am J Physiol Renal Physiol. August 1, 2019; 317(2):1522-1466.
Concomitant exposure to benzo[a]pyrene and triclosan at environmentally relevant concentrations induces metabolic syndrome with multigenerational consequences in Silurana (Xenopus) tropicalis., Usal M,Regnault C,Veyrenc S,Couturier K,Batandier C,Bulteau AL,Lejon D,Combourieu B,Lafond T,Raveton M,Reynaud S, Sci Total Environ. November 1, 2019; 689:1879-1026.
Glucocorticoid receptor is required for survival through metamorphosis in the frog Xenopus tropicalis., Sterner ZR,Shewade LH,Mertz KM,Sturgeon SM,Buchholz DR, Gen Comp Endocrinol. May 15, 2020; 291:1095-6840.
Stapled and Xenopus Glucagon-Like Peptide 1 (GLP-1)-Based Dual GLP-1/Gastrin Receptor Agonists with Improved Metabolic Benefits in Rodent Models of Obesity and Diabetes., Chen X,Fu J,Zhou F,Yang Q,Wang J,Feng H,Jiang W,Jin L,Tang X,Jiang N,Yin J,Han J, J Med Chem. November 12, 2020; 63(21):1520-4804.
Beneficial actions of the [A14K] analog of the frog skin peptide PGLa-AM1 in mice with obesity and degenerative diabetes: A mechanistic study., Musale V,Moffett RC,Conlon JM,Flatt PR,Abdel-Wahab YH, Peptides. February 1, 2021; 136:1873-5169.
Modeling endoderm development and disease in Xenopus., Edwards NA,Zorn AM, Curr Top Dev Biol. January 1, 2021; 145:1557-8933.
Stapled, Long-Acting Xenopus GLP-1-Based Dual GLP-1/Glucagon Receptor Agonists with Potent Therapeutic Efficacy for Metabolic Disease., Han C,Sun Y,Yang Q,Zhou F,Chen X,Wu L,Sun L,Han J, Mol Pharm. August 2, 2021; 18(8):1543-8392.
Genetic and Physiological Effects of Insulin on Human Urate Homeostasis., Mandal AK,Leask MP,Estiverne C,Choi HK,Merriman TR,Mount DB, Front Physiol. January 1, 2021; 12:1664-042X.
The Molecular Basis of Glucose Galactose Malabsorption in a Large Swedish Pedigree., Lostao MP,Loo DD,Hernell O,Meeuwisse G,Martin MG,Wright EM, Function (Oxf). January 1, 2021; 2(5):2633-8823.
Physical basis for distinct basal and mechanically gated activity of the human K+ channel TRAAK., Rietmeijer RA,Sorum B,Li B,Brohawn SG, Neuron. September 15, 2021; 109(18):0896-6273.
Membrane cholesterol regulates TRPV4 function, cytoskeletal expression, and the cellular response to tension., Lakk M,Hoffmann GF,Gorusupudi A,Enyong E,Lin A,Bernstein PS,Toft-Bertelsen T,MacAulay N,Elliott MH,Križaj D, J Lipid Res. January 1, 2021; 62:0022-2275.
Exposure to a mixture of benzo[a]pyrene and triclosan induces multi-and transgenerational metabolic disorders associated with decreased female investment in reproduction in Silurana (Xenopus) tropicalis., Usal M,Veyrenc S,Darracq-Ghitalla-Ciock M,Regnault C,Sroda S,Fini JB,Raveton M,Reynaud S, Environ Pollut. January 1, 2022; 292(Pt B):1873-6424.
Evidence for a Genotype-Phenotype Correlation in Patients with Pathogenic GLUT2 (SLC2A2) Variants., Grünert SC,Schumann A,Baronio F,Tsiakas K,Murko S,Spiekerkoetter U,Santer R, Genes (Basel). November 10, 2021; 12(11):2073-4425.
Ion permeation controlled by hydrophobic residues and proton binding in the proton-activated chloride channel., Cai R,Tang J,Chen XZ, iScience. November 1, 2021; 24(12):2589-0042.
Interspecies Differences in Activation of Peroxisome Proliferator-Activated Receptor γ by Pharmaceutical and Environmental Chemicals., Garoche C,Boulahtouf A,Grimaldi M,Chiavarina B,Toporova L,den Broeder MJ,Legler J,Bourguet W,Balaguer P, Environ Sci Technol. December 21, 2021; 55(24):1520-5851.
Migration of antibiotic resistance genes and evolution of flora structure in the Xenopus tropicalis intestinal tract with combined exposure to roxithromycin and oxytetracycline., Lin X,Xu Y,Xu Y,Han R,Luo W,Zheng L, Sci Total Environ. May 10, 2022; 820:1879-1026.
Pharmacological Modulation of Melanocortin 1 Receptor Signaling by Mrap Proteins in Xenopus tropicalis., Tai X,Zhang Y,Zhang Y,Yao J,Li X,Liu J,Han J,Lyu J,Lin G,Zhang C, Front Endocrinol (Lausanne). January 1, 2022; 13:1664-2392.
Advancements in the use of xenopus oocytes for modelling neurological disease for novel drug discovery., O'Connor EC,Kambara K,Bertrand D, Expert Opin Drug Discov. February 1, 2024; 19(2):1746-045X.
Amphibian host-defense peptides with potential for Type 2 diabetes therapy - an updated review., Conlon JM,Owolabi BO,Flatt PR,Abdel-Wahab YHA, Peptides. May 1, 2024; 175:1873-5169.

A gating mutation at the internal mouth of the Kir6.2 pore is associated with DEND syndrome., Proks P,Girard C,Haider S,Gloyn AL,Hattersley AT,Sansom MS,Ashcroft FM, EMBO Rep. May 1, 2005; 6(5):1469-3178.

A structural basis for the acute effects of HIV protease inhibitors on GLUT4 intrinsic activity., Hertel J,Struthers H,Horj CB,Hruz PW, J Biol Chem. December 31, 2004; 279(53):1083-351X.

Functional characterization of two naturally occurring mutations in the human sodium-phosphate cotransporter type IIa., Virkki LV,Forster IC,Hernando N,Biber J,Murer H, J Bone Miner Res. December 1, 2003; 18(12):0884-0431.

The cloning of extracellular Ca(2+)-sensing receptors from parathyroid and kidney: molecular mechanisms of extracellular Ca(2+)-sensing., Brown EM,Pollak M,Chou YH,Seidman CE,Seidman JG,Hebert SC, J Nutr. July 1, 1995; 125(7 Suppl):1541-6100.

Molecular cloning, functional expression, tissue distribution, and in situ hybridization of the renal sodium phosphate (Na+/P(i)) transporter in the control and hypophosphatemic mouse., Collins JF,Ghishan FK, FASEB J. August 1, 1994; 8(11):1530-6860.

Characterization of the defect in the Na(+)-phosphate transporter in vitamin D-resistant hypophosphatemic mice., Nakagawa N,Arab N,Ghishan FK, J Biol Chem. July 25, 1991; 266(21):1083-351X.

A heterozygous activating mutation in the sulphonylurea receptor SUR1 (ABCC8) causes neonatal diabetes., Proks P,Arnold AL,Bruining J,Girard C,Flanagan SE,Larkin B,Colclough K,Hattersley AT,Ashcroft FM,Ellard S, Hum Mol Genet. June 1, 2006; 15(11):1460-2083.

Transcription factor HNF1beta and novel partners affect nephrogenesis., Dudziak K,Mottalebi N,Senkel S,Edghill EL,Rosengarten S,Roose M,Bingham C,Ellard S,Ryffel GU, Kidney Int. July 1, 2008; 74(2):1523-1755.

Promoting ectopic pancreatic fates: pancreas development and future diabetes therapies., Pearl EJ,Horb ME, Clin Genet. October 1, 2008; 74(4):1399-0004.

An alpha7 nicotinic acetylcholine receptor-selective agonist reduces weight gain and metabolic changes in a mouse model of diabetes., Marrero MB,Lucas R,Salet C,Hauser TA,Mazurov A,Lippiello PM,Bencherif M, J Pharmacol Exp Ther. January 1, 2010; 332(1):1521-0103.

Human sodium phosphate transporter 4 (hNPT4/SLC17A3) as a common renal secretory pathway for drugs and urate., Jutabha P,Anzai N,Kitamura K,Taniguchi A,Kaneko S,Yan K,Yamada H,Shimada H,Kimura T,Katada T,Fukutomi T,Tomita K,Urano W,Yamanaka H,Seki G,Fujita T,Moriyama Y,Yamada A,Uchida S,Wempe MF,Endou H,Sakurai H, J Biol Chem. November 5, 2010; 285(45):1083-351X.

Tamm-Horsfall glycoprotein interacts with renal outer medullary potassium channel ROMK2 and regulates its function., Renigunta A,Renigunta V,Saritas T,Decher N,Mutig K,Waldegger S, J Biol Chem. January 21, 2011; 286(3):1083-351X.

Transient expression of Ngn3 in Xenopus endoderm promotes early and ectopic development of pancreatic beta and delta cells., Oropeza D,Horb M, Genesis. March 1, 2012; 50(3):1526-968X.

Towards a humanized PPARγ reporter system for in vivo screening of obesogens., Punzon I,Latapie V,Le Mével S,Hagneau A,Jolivet P,Palmier K,Fini JB,Demeneix BA, Mol Cell Endocrinol. July 15, 2013; 374(1-2):1872-8057.

The unusual stoichiometry of ADP activation of the KATP channel., Hosy E,Vivaudou M, Front Physiol. January 28, 2014; 5:1664-042X.

Recessive mutations in PCBD1 cause a new type of early-onset diabetes., Simaite D,Kofent J,Gong M,Rüschendorf F,Jia S,Arn P,Bentler K,Ellaway C,Kühnen P,Hoffmann GF,Blau N,Spagnoli FM,Hübner N,Raile K, Diabetes. October 1, 2014; 63(10):1939-327X.

Inhibitory effects of insulin on GABAA currents modulated by the GABAA alpha subunit., Williams DB, J Recept Signal Transduct Res. January 1, 2015; 35(6):1532-4281.

Autosomal-Recessive Mutations in SLC34A1 Encoding Sodium-Phosphate Cotransporter 2A Cause Idiopathic Infantile Hypercalcemia., Schlingmann KP,Ruminska J,Kaufmann M,Dursun I,Patti M,Kranz B,Pronicka E,Ciara E,Akcay T,Bulus D,Cornelissen EA,Gawlik A,Sikora P,Patzer L,Galiano M,Boyadzhiev V,Dumic M,Vivante A,Kleta R,Dekel B,Levtchenko E,Bindels RJ,Rust S,Forster IC,Hernando N,Jones G,Wagner CA,Konrad M, J Am Soc Nephrol. February 1, 2016; 27(2):1533-3450.

Xenopus as a Model for GI/Pancreas Disease., Salanga MC,Horb ME, Curr Pathobiol Rep. June 1, 2015; 3(2):2167-485X.

Xenopus as a model system for studying pancreatic development and diabetes., Kofent J,Spagnoli FM, Semin Cell Dev Biol. March 1, 2016; 51:1096-3634.

Using Xenopus to study genetic kidney diseases., Lienkamp SS, Semin Cell Dev Biol. March 1, 2016; 51:1096-3634.

Successful transfer to sulfonylureas in KCNJ11 neonatal diabetes is determined by the mutation and duration of diabetes., Babiker T,Vedovato N,Patel K,Thomas N,Finn R,Männikkö R,Chakera AJ,Flanagan SE,Shepherd MH,Ellard S,Ashcroft FM,Hattersley AT, Diabetologia. June 1, 2016; 59(6):1432-0428.

Using Xenopus to understand human disease and developmental disorders., Sater AK,Moody SA, Genesis. January 1, 2017; 55(1-2):1526-968X.

Micellar Nanomedicine of Novel Fatty Acid Modified Xenopus Glucagon-like Peptide-1: Improved Physicochemical Characteristics and Therapeutic Utilities for Type 2 Diabetes., Han J,Fei Y,Zhou F,Chen X,Zheng W,Fu J, Mol Pharm. November 6, 2017; 14(11):1543-8392.

A comparative genomics study of carbohydrate/glucose metabolic genes: from fish to mammals., Zhang Y,Zhang Y,Qin C,Yang L,Lu R,Zhao X,Nie G, BMC Genomics. April 11, 2018; 19(1):1471-2164.

Binding of sulphonylureas to plasma proteins - A KATP channel perspective., Proks P,Kramer H,Haythorne E,Ashcroft FM, PLoS One. May 15, 2018; 13(5):1932-6203.

Rational design of dimeric lipidated Xenopus glucagon-like peptide 1 analogues as long-acting antihyperglycaemic agents., Han J,Huang Y,Chen X,Zhou F,Fei Y,Fu J, Eur J Med Chem. September 5, 2018; 157:1768-3254.

Inactivation of KCNQ1 potassium channels reveals dynamic coupling between voltage sensing and pore opening., Hou P,Eldstrom J,Shi J,Zhong L,McFarland K,Gao Y,Fedida D,Cui J, Nat Commun. November 23, 2017; 8(1):2041-1723.

Activation of the calcium sensing receptor attenuates TRPV6-dependent intestinal calcium absorption., Lee JJ,Lee JJ,Liu X,O'Neill D,Beggs MR,Weissgerber P,Flockerzi V,Chen XZ,Dimke H,Alexander RT, JCI Insight. April 23, 2019; 5:2379-3708.

ANP-stimulated Na+ secretion in the collecting duct prevents Na+ retention in the renal adaptation to acid load., Cheval L,Bakouh N,Walter C,Tembely D,Morla L,Escher G,Vogt B,Crambert G,Planelles G,Doucet A, Am J Physiol Renal Physiol. August 1, 2019; 317(2):1522-1466.

Concomitant exposure to benzo[a]pyrene and triclosan at environmentally relevant concentrations induces metabolic syndrome with multigenerational consequences in Silurana (Xenopus) tropicalis., Usal M,Regnault C,Veyrenc S,Couturier K,Batandier C,Bulteau AL,Lejon D,Combourieu B,Lafond T,Raveton M,Reynaud S, Sci Total Environ. November 1, 2019; 689:1879-1026.

Glucocorticoid receptor is required for survival through metamorphosis in the frog Xenopus tropicalis., Sterner ZR,Shewade LH,Mertz KM,Sturgeon SM,Buchholz DR, Gen Comp Endocrinol. May 15, 2020; 291:1095-6840.

Stapled and Xenopus Glucagon-Like Peptide 1 (GLP-1)-Based Dual GLP-1/Gastrin Receptor Agonists with Improved Metabolic Benefits in Rodent Models of Obesity and Diabetes., Chen X,Fu J,Zhou F,Yang Q,Wang J,Feng H,Jiang W,Jin L,Tang X,Jiang N,Yin J,Han J, J Med Chem. November 12, 2020; 63(21):1520-4804.

Beneficial actions of the [A14K] analog of the frog skin peptide PGLa-AM1 in mice with obesity and degenerative diabetes: A mechanistic study., Musale V,Moffett RC,Conlon JM,Flatt PR,Abdel-Wahab YH, Peptides. February 1, 2021; 136:1873-5169.

Modeling endoderm development and disease in Xenopus., Edwards NA,Zorn AM, Curr Top Dev Biol. January 1, 2021; 145:1557-8933.

Stapled, Long-Acting Xenopus GLP-1-Based Dual GLP-1/Glucagon Receptor Agonists with Potent Therapeutic Efficacy for Metabolic Disease., Han C,Sun Y,Yang Q,Zhou F,Chen X,Wu L,Sun L,Han J, Mol Pharm. August 2, 2021; 18(8):1543-8392.

Genetic and Physiological Effects of Insulin on Human Urate Homeostasis., Mandal AK,Leask MP,Estiverne C,Choi HK,Merriman TR,Mount DB, Front Physiol. January 1, 2021; 12:1664-042X.

The Molecular Basis of Glucose Galactose Malabsorption in a Large Swedish Pedigree., Lostao MP,Loo DD,Hernell O,Meeuwisse G,Martin MG,Wright EM, Function (Oxf). January 1, 2021; 2(5):2633-8823.

Physical basis for distinct basal and mechanically gated activity of the human K+ channel TRAAK., Rietmeijer RA,Sorum B,Li B,Brohawn SG, Neuron. September 15, 2021; 109(18):0896-6273.

Membrane cholesterol regulates TRPV4 function, cytoskeletal expression, and the cellular response to tension., Lakk M,Hoffmann GF,Gorusupudi A,Enyong E,Lin A,Bernstein PS,Toft-Bertelsen T,MacAulay N,Elliott MH,Križaj D, J Lipid Res. January 1, 2021; 62:0022-2275.

Exposure to a mixture of benzo[a]pyrene and triclosan induces multi-and transgenerational metabolic disorders associated with decreased female investment in reproduction in Silurana (Xenopus) tropicalis., Usal M,Veyrenc S,Darracq-Ghitalla-Ciock M,Regnault C,Sroda S,Fini JB,Raveton M,Reynaud S, Environ Pollut. January 1, 2022; 292(Pt B):1873-6424.

Evidence for a Genotype-Phenotype Correlation in Patients with Pathogenic GLUT2 (SLC2A2) Variants., Grünert SC,Schumann A,Baronio F,Tsiakas K,Murko S,Spiekerkoetter U,Santer R, Genes (Basel). November 10, 2021; 12(11):2073-4425.

Ion permeation controlled by hydrophobic residues and proton binding in the proton-activated chloride channel., Cai R,Tang J,Chen XZ, iScience. November 1, 2021; 24(12):2589-0042.

Interspecies Differences in Activation of Peroxisome Proliferator-Activated Receptor γ by Pharmaceutical and Environmental Chemicals., Garoche C,Boulahtouf A,Grimaldi M,Chiavarina B,Toporova L,den Broeder MJ,Legler J,Bourguet W,Balaguer P, Environ Sci Technol. December 21, 2021; 55(24):1520-5851.

Migration of antibiotic resistance genes and evolution of flora structure in the Xenopus tropicalis intestinal tract with combined exposure to roxithromycin and oxytetracycline., Lin X,Xu Y,Xu Y,Han R,Luo W,Zheng L, Sci Total Environ. May 10, 2022; 820:1879-1026.

Pharmacological Modulation of Melanocortin 1 Receptor Signaling by Mrap Proteins in Xenopus tropicalis., Tai X,Zhang Y,Zhang Y,Yao J,Li X,Liu J,Han J,Lyu J,Lin G,Zhang C, Front Endocrinol (Lausanne). January 1, 2022; 13:1664-2392.

Advancements in the use of xenopus oocytes for modelling neurological disease for novel drug discovery., O'Connor EC,Kambara K,Bertrand D, Expert Opin Drug Discov. February 1, 2024; 19(2):1746-045X.

Amphibian host-defense peptides with potential for Type 2 diabetes therapy - an updated review., Conlon JM,Owolabi BO,Flatt PR,Abdel-Wahab YHA, Peptides. May 1, 2024; 175:1873-5169.